木佐貫 純嗣 | Department of Medicinal Chemistry, Kyoto Pharmaceutical University

スポンサーリンク

概要

• 同名の論文著者
• Department of Medicinal Chemistry, Kyoto Pharmaceutical Universityの論文著者

関連著者

• 木曽 良明

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 木曽 良明

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University

• 木曽 良明

  京都薬大

• 木曽 良明

  京都大学 臨病態医

• 木曽 良明

  京都薬科大学薬品化学分野

• 赤路 健一

  京都薬科大学

• 三本 勤

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 赤路 健一

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 服部 直子

  Bioscience Research Laboratories Nippon Mining Co.

• 今井 順也

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 木佐貫 純嗣

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 今井 順也

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University

• 三本 勤

  (株)ジャパンエナジー医薬・バイオ研究所

• 木佐貫 純嗣

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University:bioscience Research Laboratories N

• 田中 茂樹

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 田中 茂樹

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University

• 林 秀也

  ジャパンエナジー・医薬・バイオ研

• 高橋 治

  Pharmaceuticals & Biotechnology Laboratory Nikko Kyodo Co. Ltd.

• 高橋 治

  Bioscience Research Laboratories, Nippon Mining Co.,

• 永野 裕一

  Bioscience Research Laboratories, Nippon Mining Co.,

• 新谷 誠

  Bioscience Research Laboratories, Nippon Mining Co.,

• 林 秀也

  Bioscience Research Laboratories, Nippon Mining Co.,

• 先川 博司

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 榎本 裕志

  Department of Medicinal Chemistry, Kyoto Pharmaceutical University

• 榎本 裕志

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University

• 永野 裕一

  Bioscience Research Laboratories Nippon Mining Co.

• 先川 博司

  Department Of Medicinal Chemistry Kyoto Pharmaceutical University

• 新谷 誠

  Bioscience Research Laboratories Nippon Mining Co.

もっと見る 閉じる

著作論文

• RATIONAL DESIGN AND SYNTHESIS OF A NOVEL CLASS OF ACTIVE SITE-TARGETED HIV PROTEASE INHIBITORS CONTAINING A HYDROXYMETHYLCARBONYL ISOSTERE. USE OF PHENYLNORSTATINE OR ALLOPHENYLNORSTATINE AS A TRANSITION-STATE MIMIC
• KYNOSTATIN (KNI)-227 AND -272,HIGHLY POTENT ANTI-HIV AGENTS : CONFORMATIONALLY CONSTRAINED TRIPEPTIDE INHIBITORS OF HIV PROTEASE CONTAINING ALLOPHENYLNORSTATINE
• KNI-102,A NOVEL TRIPEPTIDE HIV PROTEASE INHIBITOR CONTAINING ALLOPHENYLNORSTATINE AS A TRANSITION-STATE MIMIC

スポンサーリンク